Stroke Trial, Recruiting NCT04445649 Sponsor: BDH-Klinik Hessisch Oldendorf Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04445649
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are in early neurological rehabilitation (sometimes called "phase B" rehabilitation)
  • People who have had a stroke, a traumatic brain injury, or a brain injury caused by lack of oxygen
  • People who have a disorder of consciousness, such as being in a coma, an unresponsive wakefulness state, or a minimally conscious state
  • People who are at least two weeks past when their brain injury or illness began
  • People who were admitted to an intensive care unit (ICU)
  • People whose legal representative (such as a family member or guardian) has provided written consent to participate
  • People for whom pregnancy has been ruled out

Who may not be able to join:

  • People whose heart or breathing is not stable enough
  • People with bone fractures or severe brain injuries in the lower part of the brain that affect hearing-related nerve signals
  • People who had a previous brain injury or brain damage before this illness
  • People with mental health conditions such as dementia or depression
  • People who are carrying bacteria that are resistant to multiple antibiotics
  • People for whom an MRI scan is not safe (for example, those with certain metal implants)
  • People who experience claustrophobia (fear of enclosed spaces)
  • People who weigh more than 120 kg

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jens D Rollnik, MD, BDH-Clinic Hessisch Oldendorf

Phone: 0049 5152 781 256

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
BDH-Klinik Hessisch Oldendorf
Registry
ClinicalTrials.gov
Start date
15 June 2020
Est. completion
15 June 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Changed functional status

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov